BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

India based Amrita University launch wearable device for home monitoring of glucose and BP

Amrita University has developed a device for home-monitoring of glucose and blood pressure. Amrita Spandanam, as the device is called, will be sold online ...

March 02, 2022 | News

GSK has launched the inaugural Shingles Awareness Week

GSK has launched the inaugural Shingles Awareness Week to educate the general public about shingles in collaboration with the International Federation on...

February 28, 2022 | News

RosVivo signed MTA for diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...

February 23, 2022 | News

First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution

Hiroshima University is home to one of the largest university research institutes in the field of radiation biomedical science in Japan. With NGS...

February 23, 2022 | News

Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders

Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company's investigational ne...

February 21, 2022 | News

Analysis of DNA reveals weapons used by our immune cells to fight Tuberculosis

The team used high-throughput genomic technologies to learn how the DNA packaging inblood cells changes when a person has active TB, a bacterial disease th...

February 17, 2022 | News

First Proton Therapy Treatment Delivered in Southeast Asia

The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...

February 09, 2022 | News

Singapore (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative ph...

February 07, 2022 | News

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

February 04, 2022 | News

Reaction Biology Announces Integrated Drug Discovery Solution

The Reaction Oncology Platform is based on a network of strategic partners, including oncology and biophysics by the US and Germany-based Reaction Biology,...

February 03, 2022 | News

Pfizer and Alex Therapeutics to provide evidence-based Digital Therapeutics to patients,

"In our efforts to give patients access to new, innovative forms of therapy, it is our aim to fully benefit from the possibilities of digitization. Alex Th...

February 01, 2022 | News

Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug

Daewoong Pharmaceutical (Daewoong) has confirmed promising phase 3 topline results that focuses on the therapeutic effects as an Enavogliflozin monotherapy...

January 26, 2022 | News

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...

January 25, 2022 | News

AHF Praises Merck for Generics – Urges Same from Vaccine Makers

“We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable ...

January 25, 2022 | News

Stay Connected